Am. Kazee et al., CLINICOPATHOLOGICAL CORRELATES IN ALZHEIMER-DISEASE - ASSESSMENT OF CLINICAL AND PATHOLOGICAL DIAGNOSTIC-CRITERIA, Alzheimer disease and associated disorders, 7(3), 1993, pp. 152-164
The neuropathologic findings from a group of 123 patients who have com
e to autopsy from the Rochester Alzheimer Disease Project (RADP) are p
resented. Among these 123 cases, there were 94 demented subjects who m
et the National Institute of Neurological and Communicative Disorders
and Stroke-Alzheimer Disease and Related Disorders Association (NINCDS
-ADRDA) clinical criteria for the diagnosis of ''probable Alzheimer di
sease,'' and 29 normal elderly controls. Autopsy confirmation of Alzhe
imer disease (AD) was based on the a age-graded National Institutes of
Health (NIH) consensus conference pathologic criteria. Using the NINC
DS-ADRDA clinical criteria and the NIH pathologic criteria, the diagno
stic accuracy was 88%, the sensitivity was 98%, and the specificity wa
s 69%. Additional strict clinical and pathologic criteria developed by
the RADP were applied in the final review of these cases to exclude a
ll confounding causes of dementia, including cerebral infarcts. After
applying these additional criteria, a subset of 62 cases of ''pure'' A
D and ''pure'' control subjects was identified for a more detailed exa
mination of neuritic plaques (NP) and neurons containing neuro-fibrill
ary tangles (NFT). The NP and NFT were counted in three subfields of h
ippocampus and two areas of association neocortex. The density of diff
use plaques (plaques lacking dystrophic neurites) was estimated on a s
emiquantitative basis. Results show that the AD patients and control g
roups could be distinguished from each other easily on the basis of me
an NP and NFT counts, but there was sufficient overlap in the counts t
o present difficulty in diagnosing any individual case. Abundant diffu
se plaque involvement and NFT in the neocortex were, however, seen onl
y in AD cases.